OVID表示,该协议支持其为癫痫相关疾病建立一流机制的战略。私人持有的Graviton专门研究抑制Rho/Rho相关的含有蛋白激酶2(ROCK2)的卷曲线圈的药物。
该团队将推进GV101的开发,目前正处于...查看全文
Ovid Therapeutics(OVID)03-21 05:25
$Ovid Therapeutics(OVID)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-24-005001 Size: 6 KB 网页链接查看全文
Ovid Therapeutics(OVID)03-08 21:35
$Ovid Therapeutics(OVID)$ 10-K Annual report [Section 13 and 15(d), not S-K Item 405] Accession Number: 0001628280-24-009809 Act: 34 Size: 32 MB 网页链接查看全文
Ovid Therapeutics(OVID)03-08 21:25
$Ovid Therapeutics(OVID)$ 8-K Current report, item 2.02 Accession Number: 0001628280-24-009807 Act: 34 Size: 275 KB 网页链接查看全文
Ovid Therapeutics(OVID)02-27 06:55
$Ovid Therapeutics(OVID)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-24-003956 Size: 5 KB 网页链接查看全文
Ovid Therapeutics(OVID)02-27 07:05
$Ovid Therapeutics(OVID)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-24-003964 Size: 5 KB 网页链接查看全文
Ovid Therapeutics(OVID)02-27 07:05
$Ovid Therapeutics(OVID)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-24-003966 Size: 7 KB 网页链接查看全文
Ovid Therapeutics(OVID)02-27 07:05
$Ovid Therapeutics(OVID)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-24-003962 Size: 5 KB 网页链接查看全文
Ovid Therapeutics(OVID)02-27 07:05
$Ovid Therapeutics(OVID)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-24-003968 Size: 5 KB 网页链接查看全文
Ovid Therapeutics(OVID)02-27 07:05
$Ovid Therapeutics(OVID)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-24-003958 Size: 5 KB 网页链接查看全文
Ovid Therapeutics(OVID.O)盘前拉升,涨超6%。 网页链接
$Ovid Therapeutics(OVID)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-24-005001 Size: 6 KB 网页链接
$Ovid Therapeutics(OVID)$ 10-K Annual report [Section 13 and 15(d), not S-K Item 405] Accession Number: 0001628280-24-009809 Act: 34 Size: 32 MB 网页链接
$Ovid Therapeutics(OVID)$ 8-K Current report, item 2.02 Accession Number: 0001628280-24-009807 Act: 34 Size: 275 KB 网页链接
$Ovid Therapeutics(OVID)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-24-003972 Size: 7 KB 网页链接
$Ovid Therapeutics(OVID)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-24-003958 Size: 5 KB 网页链接
$Ovid Therapeutics(OVID)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-24-003966 Size: 7 KB 网页链接
$Ovid Therapeutics(OVID)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-24-003960 Size: 5 KB 网页链接
$Ovid Therapeutics(OVID)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-24-003962 Size: 5 KB 网页链接
$Ovid Therapeutics(OVID)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-24-003964 Size: 5 KB 网页链接
$Ovid Therapeutics(OVID)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-24-003968 Size: 5 KB 网页链接